Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_assertion type Assertion NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_head.
- NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_assertion description "[Our findings demonstrate for the first time that Hsp27 knockdown enhances the cytotoxic effects of radiotherapy in vivo and provide preclinical proof of principle for clinical trials using Hsp27 antisense technology in the treatment of patients with HNSCC radioresistant cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_provenance.
- NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_assertion evidence source_evidence_literature NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_provenance.
- NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_assertion SIO_000772 19436268 NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_provenance.
- NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_assertion wasDerivedFrom befree-20150227 NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_provenance.
- NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_assertion wasGeneratedBy ECO_0000203 NP468582.RAVdYMrQ4cEp8wSi-hait0ZYCe5hI2zV8rpe9tZHPKgjw130_provenance.